COVID-19 mortality effects of underlying health conditions in India: a modelling study

被引:17
|
作者
Novosad, Paul [1 ]
Jain, Radhika [2 ]
Campion, Alison [3 ]
Asher, Sam [4 ]
机构
[1] Dartmouth Coll, Econ, Hanover, NH 03755 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Dev Data Lab, Washington, DC USA
[4] Johns Hopkins Univ, Paul H Nitze Sch Adv Int Studies, Int Econ, Washington, DC USA
来源
BMJ OPEN | 2020年 / 10卷 / 12期
关键词
epidemiology; health policy; public health; NEW-YORK-CITY; OUTCOMES;
D O I
10.1136/bmjopen-2020-043165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To model how known COVID-19 comorbidities affect mortality rates and the age distribution of mortality in a large lower-middle-income country (India), and to identify which health conditions drive differences with high-income countries. Design Modelling study. Setting England and India. Participants Individual data were obtained from the fourth round of the District Level Household Survey and Annual Health Survey in India, and aggregate data were obtained from the Health Survey for England and the Global Burden of Disease, Risk Factors and Injuries Studies. Main outcome measures The primary outcome was the modelled age-specific mortality in each country due to each COVID-19 mortality risk factor (diabetes, hypertension, obesity and respiratory illness, among others). The change in overall mortality and in the share of deaths under age 60 from the combination of risk factors was estimated in each country. Results Relative to England, Indians have higher rates of diabetes (10.6% vs 8.5%) and chronic respiratory disease (4.8% vs 2.5%), and lower rates of obesity (4.4% vs 27.9%), chronic heart disease (4.4% vs 5.9%) and cancer (0.3% vs 2.8%). Population COVID-19 mortality in India, relative to England, is most increased by uncontrolled diabetes (+5.67%) and chronic respiratory disease (+1.88%), and most reduced by obesity (-5.47%), cancer (-3.65%) and chronic heart disease (-1.20%). Comorbidities were associated with a 6.26% lower risk of mortality in India compared with England. Demographics and population health explain a third of the difference in share of deaths under age 60 between the two countries. Conclusions Known COVID-19 health risk factors are not expected to have a large effect on mortality or its age distribution in India relative to England. The high share of COVID-19 deaths from people under age 60 in low- and middle-income countries (LMICs) remains unexplained. Understanding the mortality risk associated with health conditions prevalent in LMICs, such as malnutrition and HIV/AIDS, is essential for understanding differential mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mortality Rate of Patients With COVID-19 Based on Underlying Health Conditions
    Choi, Won-Young
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2023, 16 (06) : 2480 - 2485
  • [2] Disparities in Underlying Health Conditions and COVID-19 Infection and Mortality in Louisiana, USA
    Kodsup, Pornpimol
    Godebo, Tewodros Rango
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2023, 10 (02) : 805 - 816
  • [3] Disparities in Underlying Health Conditions and COVID-19 Infection and Mortality in Louisiana, USA
    Pornpimol Kodsup
    Tewodros Rango Godebo
    Journal of Racial and Ethnic Health Disparities, 2023, 10 : 805 - 816
  • [4] COVID-19 and underlying health conditions: A modeling investigation
    Yang, Chayu
    Wang, Jin
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2021, 18 (04) : 3790 - 3812
  • [5] Air pollution, sociodemographic and health conditions effects on COVID-19 mortality in Colombia: An ecological study
    Rodriguez-Villamizar, Laura A.
    Carlos Belalcazar-Ceron, Luis
    Alfredo Fernandez-Nino, Julian
    Marcela Marin-Pineda, Diana
    Alberto Rojas-Sanchez, Oscar
    Alexandra Acuna-Merchan, Lizbeth
    Ramirez-Garcia, Nathaly
    Cecilia Mangones-Matos, Sonia
    Mario Vargas-Gonzalez, Jorge
    Herrera-Torres, Julian
    Milena Agudelo-Castaneda, Dayana
    Pineros Jimenez, Juan Gabriel
    Rojas-Roa, Nestor Y.
    Mauricio Herrera-Galindo, Victor
    SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 756
  • [6] Underlying conditions in adults with covid-19
    Nystad, Wenche
    Hjellvik, Vidar
    Larsen, Inger Kristin
    Ariansen, Inger
    Helland, Eyvind
    Johansen, Knut Ivar
    Gulbrandsen, Johanne
    Gulseth, Hanne Lovdal
    Eide, Helena Niemi
    Haberg, Siri E.
    Karlstad, Oystein
    Bakken, Inger Johanne
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (13) : 1340 - 1345
  • [7] Classifying the Mortality of People with Underlying Health Conditions Affected by COVID-19 Using Machine Learning Techniques
    Mohammad, RamiMustafa A.
    Aljabri, Malak
    Aboulnour, Menna
    Mirza, Samiha
    Alshobaiki, Ahmad
    APPLIED COMPUTATIONAL INTELLIGENCE AND SOFT COMPUTING, 2022, 2022
  • [8] Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
    Clark, Andrew
    Jit, Mark
    Warren-Gash, Charlotte
    Guthrie, Bruce
    Wang, Harry H. X.
    Mercer, Stewart W.
    Sanderson, Colin
    McKee, Martin
    Troeger, Christopher
    Ong, Kanyin L.
    Checchi, Francesco
    Perel, Pablo
    Joseph, Sarah
    Gibbs, Hamish P.
    Banerjee, Amitava
    Eggo, Rosalind M.
    LANCET GLOBAL HEALTH, 2020, 8 (08): : 1003 - 1017
  • [9] Sex Differences in Mortality Rates and Underlying Conditions for COVID-19 Deaths in England and Wales
    Mohamed, Mohamed O.
    Gale, Chris P.
    Kontopantelis, Evangelos
    Doran, Tim
    de Belder, Mark
    Asaria, Miqdad
    Luscher, Thomas
    Wu, Jianhua
    Rashid, Muhammad
    Stephenson, Courtney
    Denwood, Tom
    Roebuck, Chris
    Deanfield, John
    Mamas, Mamas A.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (10) : 2110 - 2124
  • [10] Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions
    Heydarifard, Zahra
    Safaei, Moslem
    Zadheidar, Sevrin
    Ehsan, Soroush
    Shafiei-Jandaghi, Nazanin Zahra
    CLINICAL CASE REPORTS, 2021, 9 (10):